ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

576.49 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	576.49
Bid (Size)	500.77 (40)
Ask (Size)	658.00 (40)
Prev. Close	576.49
Today's Range	576.49 - 576.49
52wk Range	250.05 - 626.25
Shares Outstanding	30,998,636
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks

November 27, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Azenta (NASDAQ:AZTA) and its peers.

Via StockStory

Medpace (MEDP) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Medpace (MEDP) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Performance

YTD	+72.2%	+72.2%
1 Month	-3.0%	-3.0%
3 Month	+19.8%	+19.8%
6 Month	+84.3%	+84.3%
1 Year	+69.9%	+69.9%

More News

Medpace (NASDAQ:MEDP): Strongest Q3 Results from the Drug Development Inputs & Services Group

November 24, 2025

Via StockStory

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

November 24, 2025

Via StockStory

MEDPACE HOLDINGS INC (NASDAQ:MEDP) Shows Strong Growth and Momentum Alignment ↗

November 21, 2025

Via Chartmill

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

2 Mooning Stocks to Research Further and 1 We Question

November 11, 2025

Via StockStory

Drug Development Inputs & Services Stocks Q3 Results: Benchmarking UFP Technologies (NASDAQ:UFPT)

November 11, 2025

Via StockStory

Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

November 06, 2025

Via StockStory

Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)

November 06, 2025

Via StockStory

1 Mid-Cap Stock to Target This Week and 2 We Ignore

November 02, 2025

Via StockStory

3 Cash-Heavy Stocks Worth Your Attention

October 30, 2025

Via StockStory

5 Revealing Analyst Questions From Medpace’s Q3 Earnings Call

October 29, 2025

Via StockStory

8 Analysts Assess Medpace Hldgs: What You Need To Know ↗

October 24, 2025

Via Benzinga

Medpace Soars: AI and Data Analytics Propel Clinical Trial Giant to Record Heights

October 24, 2025

Via TokenRing AI

Why Medpace Popped 13% This Week ↗

October 24, 2025

Via The Motley Fool

Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings ↗

October 24, 2025

Via Benzinga

MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook

October 23, 2025

Via StockStory

Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins ↗

October 23, 2025

Via Benzinga

Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday ↗

October 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 23, 2025

Via Benzinga

Stock Market Today: Dow Jones, Nasdaq Futures Tumble Amid US-China Trade Tensions—Tesla, IBM, American Airlines In Focus ↗

October 23, 2025

Via Benzinga

MEDPACE HOLDINGS INC (NASDAQ:MEDP) Emerges as a Top Growth and Momentum Pick ↗

October 23, 2025

Via Chartmill

Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike ↗

October 22, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 22, 2025

Via Benzinga

Frequently Asked Questions

Is Medpace Holdings, Inc. - Common Stock publicly traded?

Yes, Medpace Holdings, Inc. - Common Stock is publicly traded.

What exchange does Medpace Holdings, Inc. - Common Stock trade on?

Medpace Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Medpace Holdings, Inc. - Common Stock?

The ticker symbol for Medpace Holdings, Inc. - Common Stock is MEDP on the Nasdaq Stock Market

What is the current price of Medpace Holdings, Inc. - Common Stock?

The current price of Medpace Holdings, Inc. - Common Stock is 576.49

When was Medpace Holdings, Inc. - Common Stock last traded?

The last trade of Medpace Holdings, Inc. - Common Stock was at 12/03/25 04:00 PM ET

What is the market capitalization of Medpace Holdings, Inc. - Common Stock?

The market capitalization of Medpace Holdings, Inc. - Common Stock is 17.87B

How many shares of Medpace Holdings, Inc. - Common Stock are outstanding?

Medpace Holdings, Inc. - Common Stock has 18B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.